IIT Delhi Visible-light Unnatural Amino Acid Synthesis
Analysis based on 6 articles · First reported Aug 14, 2026 · Last updated Aug 17, 2026
This breakthrough could accelerate the development of novel pharmaceuticals and biomaterials, potentially benefiting companies in the drug discovery and biotechnology sectors. However, as an early-stage academic research finding, its immediate market impact is limited, with commercialization likely years away.
Researchers at the IIT Delhi, led by Prof Ravi P. Singh of the Department of Chemistry, have developed a visible-light-driven chemical strategy for the precise synthesis of unnatural amino acids (UAAs) and peptides. The method uses visible light and a chiral copper catalyst-ligand system to control chirality, addressing a key challenge in producing single enantiomers. Demonstrated with 43 examples, the approach starts from natural amino acid building blocks and enables the introduction of new chemical groups. This could expand the repertoire of building blocks for designing next-generation medicines, protein engineering, and advanced biomaterials. Several approved drugs, including bortezomib, octreotide, and baclofen, already use modified amino acids, highlighting the potential impact.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard